Jasper Therapeutics Inc (JSPR) — Cash Flow Quality Index

Latest as of December 2025: -2.55x

Jasper Therapeutics Inc (JSPR) has a Cash Flow Quality Index of -2.55x as of December 2025. Operating cash flow of $-21.87 Million is below net income of $8.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore JSPR long-term investments to assets to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-2.55x
Operating CF / Net Income

Operating Cash Flow

$-21.87 Million
USD

Net Income

$8.57 Million
USD

Data as of

Dec 2025
Most recent filing

Annual Cash Flow Quality Index for Jasper Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Jasper Therapeutics Inc. For live market cap and the full company financial profile, see Jasper Therapeutics Inc stock valuation.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.